Glutamate, GABA and glutathione in adults with persistent post-concussive symptoms.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2022
Historique:
received: 01 06 2022
revised: 23 07 2022
accepted: 12 08 2022
pubmed: 26 8 2022
medline: 15 12 2022
entrez: 25 8 2022
Statut: ppublish

Résumé

Persistent post-concussive symptoms (PPCS) are debilitating and endure beyond the usual recovery period after mild traumatic brain injury (mTBI). Altered neurotransmission, impaired energy metabolism and oxidative stress have been examined acutely post-injury but have not been explored extensively in those with persistent symptoms. Specifically, the antioxidant glutathione (GSH) and the excitatory and inhibitory metabolites, glutamate (Glu) and γ-aminobutyric acid (GABA), are seldom studied together in the clinical mTBI literature. While Glu can be measured using conventional magnetic resonance spectroscopy (MRS) methods at 3 Tesla, GABA and GSH require the use of advanced MRS methods. Here, we used the recently established Hadamard Encoding and Reconstruction of MEGA-Edited Spectroscopy (HERMES) to simultaneously measure GSH and GABA and short-echo time point resolved spectroscopy (PRESS) to measure Glu to gain new insight into the pathophysiology of PPCS. Twenty-nine adults with PPCS (mean age: 45.69 years, s.d.: 10.73, 22 females, 7 males) and 29 age- and sex-matched controls (mean age: 43.69 years, s.d.: 11.00) completed magnetic resonance spectroscopy scans with voxels placed in the anterior cingulate and right sensorimotor cortex. Relative to controls, anterior cingulate Glu was significantly reduced in PPCS. Higher anterior cingulate GABA was significantly associated with a higher number of lifetime mTBIs, suggesting GABA may be upregulated with repeated incidence of mTBI. Furthermore, GSH in both regions of interest was positively associated with symptoms of sleepiness and headache burden. Collectively, our findings suggest that the antioxidant defense system is active in participants with PPCS, however this may be at the expense of other glutamatergic functions such as cortical excitation and energy metabolism.

Identifiants

pubmed: 36007438
pii: S2213-1582(22)00217-0
doi: 10.1016/j.nicl.2022.103152
pmc: PMC9424629
pii:
doi:

Substances chimiques

Glutamic Acid 3KX376GY7L
gamma-Aminobutyric Acid 56-12-2
Glutathione GAN16C9B8O

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103152

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Julie M Joyce (JM)

Department of Radiology, University of Calgary, Calgary, Canada; Hotchkiss Brain Institute, Calgary, Canada; Alberta Children's Hospital Research Institute, Calgary, Canada; Integrated Concussion Research Program, Calgary, Canada. Electronic address: julie.joyce@ucalgary.ca.

Leah J Mercier (LJ)

Hotchkiss Brain Institute, Calgary, Canada; Integrated Concussion Research Program, Calgary, Canada; Department of Clinical Neurosciences, Division of Physical Medicine and Rehabilitation, University of Calgary, Calgary, Canada.

Mehak Stokoe (M)

Department of Radiology, University of Calgary, Calgary, Canada; Hotchkiss Brain Institute, Calgary, Canada; Alberta Children's Hospital Research Institute, Calgary, Canada.

Parker L La (PL)

Department of Radiology, University of Calgary, Calgary, Canada; Hotchkiss Brain Institute, Calgary, Canada; Alberta Children's Hospital Research Institute, Calgary, Canada; Integrated Concussion Research Program, Calgary, Canada.

Tiffany Bell (T)

Department of Radiology, University of Calgary, Calgary, Canada; Hotchkiss Brain Institute, Calgary, Canada; Alberta Children's Hospital Research Institute, Calgary, Canada.

Julia M Batycky (JM)

Hotchkiss Brain Institute, Calgary, Canada; Integrated Concussion Research Program, Calgary, Canada; Department of Clinical Neurosciences, Division of Physical Medicine and Rehabilitation, University of Calgary, Calgary, Canada.

Chantel T Debert (CT)

Hotchkiss Brain Institute, Calgary, Canada; Alberta Children's Hospital Research Institute, Calgary, Canada; Integrated Concussion Research Program, Calgary, Canada; Department of Clinical Neurosciences, Division of Physical Medicine and Rehabilitation, University of Calgary, Calgary, Canada.

Ashley D Harris (AD)

Department of Radiology, University of Calgary, Calgary, Canada; Hotchkiss Brain Institute, Calgary, Canada; Alberta Children's Hospital Research Institute, Calgary, Canada; Integrated Concussion Research Program, Calgary, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH